Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating VB-201 for Ulcerative Colitis has completed and reported its efficacy and safety evaluation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• VB-201

Snippet

Sponsor: Vascular Biogenics Ltd. operating as VBL Therapeutics | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED